Ossification, Heterotopic
Ossification, Heterotopic
Explore linked clinical trials. Standard reference: MESH:M001550511 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Investigate the Safety, Pharmacokinetics (PK), and Efficacy of Garetosmab in Children and Adolescents With Fibrodysplasia Ossificans Progressiva (FOP) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Nutritional and Metabolic Diseases, Ossification, Heterotopic, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, connective tissue disorder, cutaneous mucinosis, fibrodysplasia ossificans progressiva, hereditary disease, inborn carbohydrate metabolic disorder, inborn errors of metabolism, lysosomal storage disease, metabolic disease, mucopolysaccharidosis, mucopolysaccharidosis type 4, muscle tissue disorder, musculoskeletal system disorder, myositis disease, myositis ossificans | Not yet recruiting | Phase 3 | 2026-10-08 | NCT07559513 | |
| Prospective Investigation of Intra-Articular Tranexamic Acid Use in Elective Hip Arthroplasty | Hemorrhage, Ossification, Heterotopic, Pathologic Processes, Pathological Conditions, Signs and Symptoms | Active, not recruiting | Not stated | 2026-09-17 | NCT06903299 | |
| Subcutaneous Injection of Sodium Thiosulfate for Ectopic Calcifications or Ossifications. A Pilot Study | Ossification, Heterotopic, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, connective tissue disorder, dermatomyositis, muscle tissue disorder, musculoskeletal system disorder, myositis disease, nervous system disorder, neuromuscular disease, polymyositis, skin disorder, systemic sclerosis | Recruiting | Phase 2 | 2026-09-15 | NCT03582800 | |
| IL1 Inhibition in FOP | Ossification, Heterotopic, Pathologic Processes, Pathological Conditions, Signs and Symptoms, muscle tissue disorder, musculoskeletal system disorder, myositis disease, myositis ossificans | Recruiting | Not stated | 2026-08-06 | NCT06724562 | |
| A Study to Assess Safety, Tolerability and Efficacy of Garetosmab Versus Placebo Administered Intravenously (IV) in Adult Participants With Fibrodysplasia Ossificans Progressiva (FOP) | Ossification, Heterotopic, Pathologic Processes, Pathological Conditions, Signs and Symptoms, fibrodysplasia ossificans progressiva, muscle tissue disorder, musculoskeletal system disorder, myositis disease, myositis ossificans | Active, not recruiting | Phase 3 | 2026-07-17 | NCT05394116 | |
| To Assess the Efficacy, Safety, and Tolerability of INCB000928 in Participants With Fibrodysplasia Ossificans Progressiva | Ossification, Heterotopic, Pathologic Processes, Pathological Conditions, Signs and Symptoms, muscle tissue disorder, musculoskeletal system disorder, myositis disease, myositis ossificans | Recruiting | Phase 2 | 2026-05-22 | NCT05090891 | |
| Multi-centre Study to Evaluate ACAF Versus Laminoplasty in Treating Cervical Ossification of the Posterior Longitudinal Ligament | Ossification, Heterotopic, Pathologic Processes, Pathological Conditions, Signs and Symptoms, bone disorder, musculoskeletal system disorder, ossification of the posterior longitudinal ligament of the spine, vertebral column disorder | Active, not recruiting | Not applicable | 2026-05-13 | NCT04968028 | |
| The Fibrodysplasia Ossificans Progressiva (FOP) Registry | Bone Diseases, Developmental, Foot Deformities, Hallux Valgus, Neoplasms by Histologic Type, Neoplasms, Bone Tissue, Neoplasms, Connective and Soft Tissue, Ossification, Heterotopic, Osteochondroma, Pathologic Processes, Pathological Conditions, Signs and Symptoms, bone disorder, connective tissue neoplasm, muscle tissue disorder, musculoskeletal system disorder, myositis disease, myositis ossificans, neoplasm, osteochondrodysplasia | Recruiting | Not stated | 2026-04-08 | NCT02745158 | |
| A Study of Andecaliximab in Participants With Fibrodysplasia Ossificans Progressiva (FOP) | Foot Deformities, Hallux Valgus, Inflammation, Ossification, Heterotopic, Pathologic Processes, Pathological Conditions, Signs and Symptoms, fibrodysplasia ossificans progressiva, muscle tissue disorder, musculoskeletal system disorder, myositis disease, myositis ossificans, nervous system disorder, neuromuscular disease | Active, not recruiting | Phase 2 / Phase 3 | 2025-10-14 | NCT06508021 | |
| A Study of Andecaliximab in People With Spinal Cord Injury at Risk for Bone Growth Outside of the Normal Skeleton. | Ossification, Heterotopic, Pathologic Processes, Pathological Conditions, Signs and Symptoms | Recruiting | Phase 1 / Phase 2 | 2025-06-17 | NCT07024407 | |
| Continuous Passive Motion Versus Heterotopic Ossification | Brain Injuries, Traumatic, Craniocerebral Trauma, Ossification, Heterotopic, Pathologic Processes, Pathological Conditions, Signs and Symptoms, brain disorder, brain injury, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, injury, nervous system disorder, nervous system injury, spinal cord disorder, spinal cord injury, stroke disorder, vascular disorder | Recruiting | Not applicable | 2024-12-06 | NCT05906056 |